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Abstract Intramuscular acidosis is a contributing factor
to fatigue during high-intensity exercise. Many nutritional
strategies aiming to increase intra- and extracellular
buffering capacity have been investigated. Among these,
supplementation of beta-alanine (*3–6.4 g/day for
4 weeks or longer), the rate-limiting factor to the intra-
muscular synthesis of carnosine (i.e. an intracellular buf-
fer), has been shown to result in positive effects on exercise
performance in which acidosis is a contributing factor to
fatigue. Furthermore, sodium bicarbonate, sodium citrate
and sodium/calcium lactate supplementation have been
employed in an attempt to increase the extracellular
buffering capacity. Although all attempts have increased
blood bicarbonate concentrations, evidence indicates that
sodium bicarbonate (0.3 g/kg body mass) is the most
effective in improving high-intensity exercise performance.
The evidence supporting the ergogenic effects of sodium
citrate and lactate remain weak. These nutritional strategies
are not without side effects, as gastrointestinal distress is
often associated with the effective doses of sodium bicar-
bonate, sodium citrate and calcium lactate. Similarly,
paresthesia (i.e. tingling sensation of the skin) is currently
the only known side effect associated with beta-alanine
supplementation, and it is caused by the acute elevation in
plasma beta-alanine concentration after a single dose of
beta-alanine. Finally, the co-supplementation of beta-ala-
nine and sodium bicarbonate may result in additive
ergogenic gains during high-intensity exercise, although
studies are required to investigate this combination in a
wide range of sports.
1 Introduction
High-intensity exercise requires maximal or near-maximal
intensity efforts resulting in rapid changes in the intra-
muscular metabolic profile. These changes include sub-
strate depletion [1] and metabolite accumulation and are
accompanied by muscular fatigue [2]. Exercise-induced
muscle fatigue, defined as the inability of the skeletal
muscle to maintain a particular tension or a given exercise
intensity [3], has been a focal point of research for many
decades. However, the exact mechanisms that contribute to
fatigue remain poorly understood; fatigue is a complex and
multifactorial phenomenon that varies depending on the
type, intensity and duration of the exercise. In the particular
case of high-intensity short-duration exercise, several
contributing factors appear to be of particular concern to
the onset of muscle fatigue, including the accumulation of
potassium ions (K?) in the interstitium of the muscle cell
[4], decreased release/uptake of calcium ions (Ca2?) from/
to the sarcoplasmic reticulum [5], the depletion of energy
substrates, and the accumulation of metabolites within the
muscle cell [6].
Metabolite accumulation has long been considered one
of the factors contributing to reduced exercise performance
and capacity with the accumulation of hydrogen ions (H?),
which causes acidification in the muscle, associated with
muscle fatigue [2, 3, 7–10]. Analyses of muscle samples
have consistently shown that pH values can decline from
*7.1 (at rest) to *6.5 following high-intensity exercise to
exhaustion [11–13]. The role of pH and the exact
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physiological mechanisms leading to fatigue remain con-
troversial and are still under intense debate and investiga-
tion. Nonetheless, there is evidence to support the
following roles of muscle acidosis in fatigue development:
(1) competition of H? with Ca2? ions for the troponin
binding site, impairing the ability of the contractile
machinery to effectively operate [14, 15]; (2) inhibition of
phosphorylcreatine resynthesis [16]; and (3) inhibition of
key enzymes of the glycolytic pathway, such as glycogen
phosphorylase and phosphofructokinase [17]. These effects
may limit the ability of the muscle cells to cope with the
high energy demand during exercise and result in a
reduction in intensity and/or performance or complete
cessation of exercise.
The human body contains well-regulated mechanisms to
maintain the intracellular and extracellular pH within the
physiological range, including intracellular buffers, extra-
cellular buffers, dynamic buffering systems, as well as
respiratory and renal mechanisms for pH regulation [18,
19]. During high-intensity exercise, acid–base balance in
muscle is mainly regulated by intracellular, extracellular
and dynamic buffering (Fig. 1). Intracellular physico-
chemical buffering represents the immediate defence
against the accumulation of H? in the contracting muscle.
This is mediated primarily by phosphates, proteins and
dipeptides, which exert their buffering action in the cyto-
sol, where pH is closer to the acid dissociation constant
(Ka) of these substances. Muscle pH homeostasis is also
regulated by active and passive transport of H? into the
surrounding interstitium, where they are buffered by cir-
culating buffers, pulmonary ventilation and the kidneys.
The flux of H? out of the muscle during exercise is facil-
itated by MCT1 and MCT4, monocarboxylate transport
proteins that carry monocarboxylates (i.e. lactate) across
cell membranes, as well as by other transporting systems
such as the sodium–hydrogen exchanger and the sodium
bicarbonate co-transporter. In the blood, the chemical
buffering system is primarily composed of bicarbonate
(HCO3
-), which has the ability to bind H? [20].
The importance of the buffering systems in combating
fatigue has led to increasing interest in nutritional strategies
capable of increasing both intracellular and extracellular
buffering capacity. This has led to a number of original
investigations on a variety of supplements, including beta-
alanine, sodium bicarbonate, sodium citrate, sodium and
calcium lactate, with several narrative, systematic and
meta-analytic reviews published on these topics [21–27].
The current review aims to summarise the available liter-
ature on all nutritional strategies aimed at increasing
buffering capacity in light of more recent evidence and to
highlight their underlying physiological mechanisms of
action, effects on high-intensity exercise capacity and
performance, and possible side effects.
2 Beta-Alanine
2.1 Mechanisms of Action
Beta-alanine is a non-essential and non-proteinogenic
amino acid produced endogenously in the liver from the
degradation of uracil [28]. Alternative synthesis from
pathways in the gut [29] and kidney [30] might also
account for some endogenous production of beta-alanine,
although the very low fasting concentrations in blood [31]
suggest that endogenous synthesis is rather low and does
not constitute a significant source of beta-alanine for the
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Fig. 1 High-intensity exercise increases the energy demand of the
muscle, which is met by aerobic and anaerobic energy sources. a The
primary contributions of ATP degradation and anaerobic glycolysis to
the production of H? during exercise. Physico-chemical buffers (e.g.
carnosine) represent the first line of defence against changes in
muscle pH, and are the only defence during exercise when blood flow
is occluded. b The carnosine molecule with its imidazole side chain
where the accumulating H? are buffered. In addition to intracellular
buffering, transmembrane H? transport is a major controller of pH
during dynamic exercise. c The main transporters, including the
sodium–hydrogen exchanger (NHE), the sodium bicarbonate co-
transporter (NBC) and the monocarboxlate transporter (MCT1,
MCT4). The circulating H? are subsequently buffered by bicarbonate
anions. ADP adenosine diphosphate, ATP adenosine triphosphate
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carnosine synthesis in skeletal muscle, a reaction catalysed
by the enzyme carnosine synthase [32, 33].
Carnosine is a cytoplasmic dipeptide abundantly found
in excitable tissues, such as skeletal muscle [31], heart [34]
and in some brain regions [35], although the highest con-
centrations of carnosine in humans are found in skeletal
muscle. Several physiological functions have been attrib-
uted to carnosine in skeletal muscle, including antioxidant
activity [36] and protection against protein glycation and
carbonylation [37, 38]. Data from in-vitro studies with
animal and human muscle fibres have also attributed other
functions to carnosine, including calcium sensitising, reg-
ulation of the calcium transient (i.e. increased calcium
release and reuptake from the sarcoplasmic reticulum), and
excitation-contraction coupling [37, 39]. However, a recent
whole-body study with humans did not support the
hypothesis of increased carnosine to increase calcium
sensitivity and calcium release, but supported the finding
that carnosine may improve calcium reuptake [40]. Clearly,
more studies investigating these issues are still required to
clarify the physiological roles of carnosine. Despite some
controversy, an undisputed function of carnosine is intra-
cellular pH regulation [31], since its side chain (i.e. the
imidazole ring) has a pKa of 6.83 [41, 42], making car-
nosine an obligatory physicochemical buffer. Since the
pKa of carnosine is optimal for buffering within the muscle
during high-intensity exercise, it could be an important
contributor to performance and tolerance to exercises that
are limited by H? accumulation.
Carnosine synthase, the enzyme responsible for carno-
sine synthesis in skeletal muscle, has a greater affinity, as
indicated by its Michaelis–Menten constant (Km), for L-
histidine (Km *16.8 lmol/L) than for beta-alanine (Km
*1–2.3 mmol/L) [43, 44]. Moreover, plasma and intra-
muscular concentrations of L-histidine are substantially
higher than beta-alanine [45]. Consequently, beta-alanine
availability is the rate-limiting factor for the endogenous
synthesis of carnosine within skeletal muscle. Subse-
quently, beta-alanine supplementation (over a period of
2 weeks or longer) induces significant increases in muscle
carnosine content [31, 46, 47]. The typical increase in
muscle carnosine following beta-alanine supplementation
is 60–80 %, which is estimated to elevate the contribution
of carnosine to whole muscle H? buffering by
*2.7–5.3 mEq H?/kg dry mass over the exercise pH range
[31], corresponding to an *3–5 % increase in muscle
buffering capacity. Although this is a conservative estimate
of the contribution to the whole muscle, the specific con-
tribution to the buffering capacity of type II fibres is con-
siderably greater. Theoretically, such an increase in
intracellular buffering capacity could translate into con-
comitant increases in performance and capacity during
exercise limited by increasing muscle acidosis.
2.2 Effects on High-Intensity Exercise
A meta-analysis of the available evidence on beta-alanine
and exercise [24] showed that beta-alanine improved
exercise to a greater extent than placebo. The positive
effect was due to improvements in exercise capacity tests
but not performance tests, though this may have been due
to the relatively low number of performance studies at the
time of analysis. Since a capacity test requires the indi-
vidual to exert to the point of volitional exhaustion, as
opposed to a fixed point of cessation in a performance test,
thereby resulting in a maximal production of H?, these data
support the role of carnosine in acid–base balance. A
highly significant effect was shown for exercises lasting
60–240 s, which strengthens the suggestion that the pri-
mary role of muscle carnosine is pH buffering. With the
growing popularity of beta-alanine, numerous investiga-
tions have been published since this meta-analysis and
have shed further light on the ergogenic potential of this
nutritional supplement.
There is clear evidence that exercises shorter than 60 s
are unaffected by beta-alanine [48–50]. This consistent
outcome contrasts the purported role of increased carnosine
to increase the calcium sensitivity of the muscle and the
calcium release from sarcoplasmic reticulum. This was
confirmed by Hannah et al. [40], who showed no effect of
beta-alanine on maximum and explosive voluntary con-
tractions, but there was a reduction in half-relaxation time,
suggesting an enhanced reuptake of calcium. Further
mechanistic studies are required to determine the role of
carnosine in calcium handling.
Several studies have shown the efficacy of increased
muscle carnosine content through beta-alanine supple-
mentation on high-intensity exercises lasting 1–4 min;
exercise performance and capacity have been improved in
a variety of cycling [46, 51–54], running [55, 56], and
repeated-bout upper- and lower-body protocols [57, 58].
The majority of research reporting an ergogenic effect of
beta-alanine supplementation is on exercise lasting
1–10 min, although not all agree [59–62]. Improvements in
high-intensity cycling capacity at 110 % of maximum
power output, a reliable cycling capacity test designed to
last between 120–240 s [63], have consistently been
shown, with improvements of 11.9 % [46], 12.1 % [54]
and 14.0 % [64] in time-to-exhaustion in recreationally
active participants following beta-alanine supplementation.
These studies highlight the consistency in responses across
individuals following supplementation during a high-in-
tensity test limited by increasing acidosis.
Hobson et al. [24] showed an effect of beta-alanine on
exercise lasting more than 240 s, although this result was
likely due to the incremental nature of many of the tests
employed, which are very low in intensity in the earlier
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stages [51, 52]. Two studies did not show any improvement
on prolonged cycling time trial performance [53, 62],
which is in line with the role of carnosine as an intra-
muscular buffer since fatigue during exercise of this
duration is not associated with increasing acidosis.
Some doubt has been raised concerning the efficacy of
b-alanine on athletes since sprint-trained individuals have
been shown to have an elevated buffering capacity com-
pared with their non-trained and endurance-trained coun-
terparts [65, 66]. It has been argued that previously
elevated muscle buffering capacity could minimise any
improvements brought about via increased carnosine. This
has gained some support from indirect evidence in studies
with well-trained athletes who supplemented with beta-
alanine and showed no improvements in performance [48,
50, 59, 60]. However, a recent study in our laboratory,
specifically designed to address this topic, investigated the
effects of beta-alanine supplementation on high-intensity
cycling performance in both trained cyclists and non-
trained individuals. Both groups showed a similar
improvement in total work done (*3 %) following sup-
plementation [58], indicating that beta-alanine is equally
efficient in untrained and athletic populations. Indeed, there
is now a growing body of evidence to support the effective
use of beta-alanine among the elite athletic populations;
athletes involved in 100- and 200-m freestyle swimming
[67], 2000-m rowing [68–70] and 800-m running [55].
2.3 Possible Side Effects
The only currently known side effect reported in the lit-
erature from the use of beta-alanine is paraesthesia, which
has been described as a prickly sensation on the skin that
starts within 10–20 min following ingestion and lasts up to
1 h [31]. These symptoms typically arise from high doses
of beta-alanine and are associated with the peak plasma
beta-alanine level [31]. It has been suggested that beta-
alanine stimulates a specific G-protein-coupled receptor
expressed by sensory neurons located at the surface of the
skin [71]. Although harmless, paraesthesia is unpleasant
and may compromise the blinding of a research investi-
gation; therefore, dosing strategies aiming to avoid
paraesthesia are employed. To circumvent the occurrence
of paraesthesia, studies have consistently staggered dosing
protocols throughout the day. Harris et al. [31] were suc-
cessful in reducing the incidence of paraesthesia with
multiple doses of 800 mg every 3 h. A new sustained-re-
lease formulation has been developed that results in a lower
peak plasma concentration from a single dose while release
into blood and uptake into muscle is maintained over 6 h
with minimal side effects [72].
In light of the current evidence suggesting no major side
effects other than paraesthesia during supplementation of
2–16 weeks in duration [46, 47, 73], athletes can safely
supplement with beta-alanine for this period of time prior
to competition or throughout training. Future research
should ascertain as to whether longer-term supplementa-
tion ([16 weeks) is free of any other side effects, although
the preliminary results of a study we are currently con-
ducting showed that beta-alanine supplementation did not
alter clinical markers of health in 16 subjects who sup-
plemented for 6 months.
3 Sodium Bicarbonate
3.1 Mechanisms of Action
Bicarbonate is a blood buffer that plays an important role in
maintaining both extracellular and intracellular pH, despite
its inability to permeate the sarcolemma [12, 74]. Under
normal resting conditions, circulating concentrations of
bicarbonate range between 23 and 27 mmol/L [75]. Studies
investigating acute sodium bicarbonate supplementation to
increase blood bicarbonate levels have used doses relative
to body mass (BM), ranging from as little as 0.1 g/kg,
increasing to as much as 0.5 g/kg BM [76]. Sodium
bicarbonate supplementation has consistently caused blood
alkalosis [12, 77, 78] accompanied by an increase in blood
bicarbonate concentrations (for a review, see Carr et al.
[22]).
As a consequence of increased blood pH and HCO3
-,
there is a parallel increase in the intracellular/extracellular
gradient of H?, enhancing the activity of the lactate/H? co-
transporters [79–81], ultimately leading to a greater efflux
of H? and lactate out of the active muscles and into the
circulation, where they are buffered or can be taken up into
adjacent [82] or inactive [83] muscle fibres. Therefore,
sodium bicarbonate ingestion increases the extracellular
buffering and dynamic buffering capacity, increasing the
rate at which accumulating H? is removed from the
working muscles during high-intensity exercise, which
ultimately contributes to intramuscular pH maintenance.
An attenuation of H? accumulation in the working muscle
would allow the contractile process and the resynthesis of
adenosine triphosphate (ATP) by glycolysis to continue
under more favourable conditions, thereby delaying the
onset of muscle fatigue during high-intensity exercise.
3.2 Effects on High-Intensity Exercise
The effects of sodium bicarbonate supplementation on
exercise performance and capacity have been well resear-
ched. In a meta-analysis of the literature, Carr et al. [22]
showed that sodium bicarbonate was effective at improving
a 1-min all-out bout by 1.7 ± 2.0 % (mean ± 95 %
S74 A. H. Lancha Junior et al.
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confidence limits) when ingested at a dose of 0.3 g/kg BM
prior to exercise. The ergogenic effects of sodium bicar-
bonate were enhanced with increasing doses and sprint
bouts, though a dose of 0.3 g/kg BM is generally consid-
ered optimal since McNaughton [76] showed no further
improvements in 60 s of cycling with increasing doses.
An improvement of 1.7 % in performance may appear
to be minor, but it is important to highlight the discrepancy
between studies that have contributed to inconsistent
results. Methodological differences such as differing dos-
ing regimens, exercise types and intensities as well as side
effects and individual variation have likely contributed to
differing performance improvements, potentially masking
the true magnitude of the performance effect of sodium
bicarbonate. Saunders et al. [84] showed a large inter-in-
dividual ergogenic response to sodium bicarbonate while
also highlighting the negative impact that the associated
side effects can have on performance. It also has been
suggested that general analyses of intervention studies do
not account for a potentially high variation within indi-
viduals which may compromise the magnitude of effect of
an intervention. Therefore, caution should be exercised
when interpreting mean and pooled data regarding the
efficacy of sodium bicarbonate as an ergogenic aid.
However, it is important to highlight several individual
studies, particularly those employing multiple bouts of
supramaximal exercise, since exercise of this type may
elicit higher muscle acidosis than continuous supramaxi-
mal exercise [85, 86]. Studies using multiple bouts of high-
intensity exercise have consistently shown performance
improvements in excess of 8 % [57, 87, 88]. In addition,
there is evidence to suggest that sodium bicarbonate is also
beneficial to sport-specific performance in a variety of
disciplines where the metabolic demands are predomi-
nantly anaerobic, such as judo, swimming, boxing and
water polo [89–92]. This also suggests that the ergogenic
effects observed in exercise capacity tests can be translated
into performance improvements in real sport settings.
3.3 Possible Side Effects
The ergogenic potential of sodium bicarbonate appears to
be highly variable, with acute gastrointestinal side effects
associated with supplementation a possible confounding
factor that may preclude improvements in performance
[84]. Ingestion of sodium bicarbonate results in the release
of HCO3
- within the stomach, which is swiftly neutralised
by the H? found in the stomach’s gastric juice, which leads
to increased CO2 production, and may cause abdominal
pain, flatulence, nausea, diarrhoea and even vomiting [93].
Incidence and severity of symptoms differ between indi-
viduals [65] and may also be influenced by dose, as
McNaughton [76] reported increased gastrointestinal
disturbance in all participants consuming doses above
0.3 g/kg BM.
Several strategies have been adopted in order to min-
imise the discomfort associated with acute sodium bicar-
bonate supplementation, including multiday ingestion [94],
chronic administration [95] and split-dose protocols [54,
96]. However, the large doses used in chronic supple-
mentation protocols (normally 500 mg/kg/day) present
other obstacles that may prevent athletes from taking
sodium bicarbonate, such as the excessive amount of
sodium ingested over a relatively long period and the
continuous sensation of satiety due to the excessive number
of capsules. Furthermore, split-dose strategies may still
lead individual to experience severe gastrointestinal dis-
comfort [84]. Future research should try to solve the
challenges inherent in the use of this nutritional supple-
ment, focusing on alternatives that minimise the dose and/
or attenuate the side effects associated with sodium bicar-
bonate supplementation. Athletes should engage in sup-
plementation during pre-season or training to determine
their tolerance to the supplement.
4 Sodium Citrate
4.1 Mechanisms of Action
Sodium citrate is another agent capable of increasing
extracellular buffering capacity. Upon ingestion, it is
rapidly dissociated to its constituent ions; the citrate anion
is expelled from the plasma, leading to a change in the
electrical equilibrium [97, 98]. In order to recover this
equilibrium, a decrease of H? in plasma occurs as well as a
resultant increase in HCO3
-, enhancing the extracellular
buffering capacity [99].
The increase in blood pH through sodium citrate sup-
plementation facilitates a greater efflux of H? and lactate
from the active muscles via monocarboxylate transporter
proteins that carry monocarboxylates across the cell
membrane [100]. Potteiger et al. [101] showed peak values
of pH and HCO3
- in blood 100–120 min following the
ingestion of 0.5 g/kg BM of sodium citrate, suggesting this
timing strategy may be most effective in increasing
extracellular buffering capacity, though the most effective
dose remains yet to be elucidated.
4.2 Effects on High-Intensity Exercise
The effects of sodium citrate on exercise have been well
documented, with numerous original investigations assess-
ing its ergogenic capacity [97–112]. However, the results
are inconsistent, as revealed by a meta-analysis showing an
unclear effect on performance of 0.0 ± 1.3 % [22]. Early
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studies investigating the potential ergogenic effects of this
nutritional strategy did not show any positive effects of
0.3 g/kg BM sodium citrate on a variety of exercise pro-
tocols [97, 98, 102]. Later, McNaughton [103] showed that
0.5 g/kg sodium citrate was a more favourable dose to
optimise anaerobic performance. Indeed, McNaughton and
Cedaro [99] demonstrated that this dose of sodium citrate
significantly improved high-intensity cycling lasting
120–240 s. In exercise protocols of shorter duration (i.e. 10-
and 30-s cycling protocols), performance was not improved
by an equivalent dose, likely because buffering capacity is
not critical to performance in such short protocols. The
ergogenic effect of sodium citrate on high-intensity cycling
1–4 min in duration has been further demonstrated using a
supramaximal cycling test [102–104].
The effects of sodium citrate on running appears more
uncertain, with a 0.5 g/kg BM dose showing only a 50 %
likelihood of an improvement in an all-out sprint to
exhaustion in endurance athletes [105]. Further sport-
specific running protocols have provided more equivocal
results. A low dose of 0.3 g/kg did not improve 600-m
running performance in female athletes and non-athletes
[106], whereas a higher dose of 0.5 g/kg did improve
3000-m running performance in male and female athletes
[107] and 5000-m running performance in well-trained
college runners [108]. However, further research from this
group has yielded contrasting evidence with no effect of an
equivalent dose on 5-km time trial in trained male runners
[109] or 1500-m performance in trained female middle-
distance runners [110] following 0.4 g/kg sodium citrate.
Furthermore, sodium citrate was equally unable to improve
repeated 60-s sprints in moderately active males [111].
Assessment of the literature reveals a variable exercise
response following sodium citrate supplementation, with an
apparent increased efficacy during cycling versus running
protocols. Isolated muscle groups may be more susceptible
to local acidosis than whole body exercise. This may explain
the lower effectiveness of increased buffering capacity on
running as compared with cycling protocols. Nonetheless,
caution should be exercised when interpreting these results
because of differences in supplementation doses. Further-
more, the absence of well-controlled familiarisation sessions
and standardisation of the gender and training status within a
study cannot be ruled out as possible factors leading to
inconsistency in results. Further studies should be conducted
covering all these limitations in order to better evaluate the
true ergogenic efficacy of sodium citrate.
4.3 Possible Side Effects
Sodium citrate is frequently employed as an alternative to
sodium bicarbonate because of the common belief that it
results in decreased side effects. Despite this, individuals
have reported thirst, nausea and headaches following
ingestion of 0.5 g/kg BM sodium citrate, with all inci-
dences occurring within the first 60 min post-ingestion
[103]. Similarly, several participants reported symptoms of
gastrointestinal discomfort and stomach cramps following
0.5 g/kg [112] and 0.6 g/kg [109] of sodium citrate,
although not all participants in these studies reported dis-
comfort. However, there is sufficient evidence to suggest
that the ingestion of sodium citrate may cause discomfort
that may negate any performance benefits through
increased buffering capacity. The individual variability
suggests that the efficacy of this strategy should be indi-
vidually tested by athletes in training prior to actual
competitions.
5 Sodium Lactate and Calcium Lactate
5.1 Mechanisms of Action
Lactate supplementation has been suggested as a strategy
capable of increasing extracellular buffering capacity [105,
113]. The lactate ingested is absorbed preferentially at the
jejunum, through the sodium-coupled intestinal lactate
transporter (sMCT), also known as the SLC5A8 [114–116].
Once in the bloodstream, it can be taken up by several
tissues, including skeletal muscle, where it is oxidised
[117]. Alternatively, lactate can be taken up by hepato-
cytes, where it is converted into glucose [118]. In both
reactions, there is a net consumption of H?, which could
indirectly spare blood bicarbonate and increase blood pH
[113, 119], increasing lactate and H? efflux from the
muscle, therefore decreasing intramuscular H? concentra-
tion [79, 80].
Research has investigated both the effects of sodium
lactate and calcium lactate, though it is currently unknown
how they differ in terms of their alkalosis-inducing effects.
Due to the sodium-coupled transport of lactate at the
jejunum [114–116], one might speculate that sodium lac-
tate would be absorbed faster than calcium lactate. The fact
is that there are currently no dose-response studies on oral
sodium lactate ingestion or directly comparing blood pH
and HCO3
- responses between calcium and sodium lactate.
However, data from our laboratory showed that the
ingestion of 150 and 300 mg/kg BM of calcium lactate
induced a small, yet significant, increase in blood pH and
HCO3
- [120], with peak values being attained 90 min
post-ingestion. Interestingly, there were no differences in
blood pH and HCO3
- following the different doses, sug-
gesting that 150 mg/kg may be sufficient, though further
research is needed.
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5.2 Effects on High-Intensity Exercise
Since the use of lactate supplementation as a buffering agent
is relatively novel, the available evidence of its ergogenic
potential is scarce and controversial. Van Montfoort et al.
[105] were the first to investigate the buffering efficacy of
lactate, supplementing individuals with 400 mg/kg BM
sodium lactate, with participants run to exhaustion 90 min
post-ingestion. Exercise capacity was improved with sodium
lactate by 1.7 % compared with placebo, with an 83 %
likelihood of the difference being meaningful. Subsequently,
Morris et al. [113] supplemented trained cyclists with
120 mg/kg calcium lactate 80 min prior to exercise and
showed a performance improvement of 17 % compared with
placebo during a cycle-to-exhaustion protocol following a
supramaximal multiple-bout protocol. Although the results
of both studies are encouraging, the discrepancy between
doses and subsequent exercise improvements suggested that
further research is required.
In order to gain further insight into this emerging sup-
plement, our research group investigated the acute effects of
two different dosages of calcium lactate (150 and 300 mg/kg
BM) on high-intensity intermittent performance in the form
of three upper-body arm-crank bouts (this protocol has
previously been shown to be sufficiently sensitive to detect
performance changes due to increased buffering capacity)
[57, 58, 89]. Despite significant increases in blood pH and
HCO3
-, no improvements in performance were shown with
either dose [120]. These data have cast some doubt and
further controversy on the efficacy of lactate supplementa-
tion as the dosing protocols are very similar between all
these studies. A possible explanation for the beneficial
effects of lactate supplementation in the previous studies,
but not in ours, would be related to the exercise protocols.
Van Montfoort et al. [105] and Morris et al. [113] employed
lower-body time-to-exhaustion protocols, and capacity tests
are generally less reliable than performance tests and have
been known to have coefficients of variation in excess of
10 % [121]. Furthermore, the repeated-bout Wingate-like
test employed by our group was an intermittent upper-body
performance test, which results in even greater acidosis than
leg cycling exercises [122], and theoretically would make
our protocol more sensitive to detect the effects of calcium
lactate ingestion on performance. In view of this, future
studies should investigate different exercise performance
protocols and different supplementation protocols, such as
chronic administration of lactate, which could result in a
more pronounced blood alkalosis.
5.3 Possible Side Effects
The only reported side effects from sodium/calcium lactate
supplementation resulted from a recent study conducted in
our laboratory [120]. Low- and high-dose calcium lactate
supplementation induced eructation and flatulence to a
similar extent. No side effects were reported in other
studies [105, 115]. Though initial reports appear favour-
able, only further research will determine whether different
doses and types of lactate supplementation will result in
any detrimental side effects.
6 Co-Supplementation
6.1 Mechanisms of Action
The buffering systems of the human body are complex and
work simultaneously to maintain intracellular and extra-
cellular homeostasis. Since these systems do not work
independently, it could be hypothesised that an increase in
the capacity of multiple buffering systems would lead to a
better improvement in pH regulation. In line with this,
several studies have investigated the effects of co-supple-
mentation of buffering agents. However, since sodium
bicarbonate, sodium citrate and sodium/calcium lactate
result in the same physiological response (i.e. increased
blood pH and HCO3
-), studies on co-supplementation are
limited to the use of a buffering agent capable of increasing
extracellular buffering capacity combined with beta-ala-
nine (capable of increasing intracellular buffering capac-
ity). This could lead to an increase in intracellular H?
buffering while simultaneously increasing the efflux of H?
out of the working muscle. Another limiting factor for the
combination of bicarbonate, citrate and/or lactate is the
high dose required, and given that one supplement may
cause gastrointestinal disturbances, adding high doses of
more than one of these alkalising agents is likely to be
impractical.
6.2 Effects on High-Intensity Exercise
Sale et al. [54] were the first to investigate the effect of co-
supplementation of beta-alanine and sodium bicarbonate
on high-intensity cycling capacity. Although null-hypoth-
esis significance testing indicated there was no benefit of
co-supplementation above beta-alanine alone, magnitude-
based inferences showed a 70 % likelihood that the dif-
ferences observed were meaningful. This is in contrast to
the results of Bellinger et al. [59], where trained cyclists
showed no further performance benefits in 4 min of cycling
when co-supplemented. However, the cyclists in this study
showed no performance gains with beta-alanine alone, but
did with sodium bicarbonate. Since it was expected that
increased buffering capacity would improve performance
regardless of nutritional strategy, these results are some-
what surprising and test performance may have been
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influenced by pacing strategies. Further research on single-
bout high-intensity exercise has suggested that co-supple-
mentation may lead to small additive gains in 100- and
200-m swimming time-trial performance [67].
Repeated-bout high-intensity exercise may induce a
greater severity of muscle acidosis, particularly in the latter
bouts [86], leading to several studies that have investigated
the effects of co-supplementation of beta-alanine and
sodium bicarbonate on exercise of this type. No beneficial
effects were shown on repeated bouts of\10 s in duration
[96, 123]. However, clear additive gains were shown dur-
ing four bouts of 30-s arm-cranking in trained grappling
athletes [57]. Interestingly, there was an *7 % improve-
ment in total work done following supplementation with
beta-alanine and sodium bicarbonate alone, and this was
doubled to 14 % with co-supplementation. The clear
additive effect of co-supplementation shown in this study is
in contrast to previous research, though results may be due
to the chronic sodium bicarbonate supplementation proto-
col employed in this study. However, pre-exercise blood
pH and bicarbonate values were not determined, so it is
unknown whether chronic supplementation resulted in
greater blood alkalosis. Another explanation may be related
to the exercise protocol used in this study. The four-bout
upper-body test has been shown to elicit extreme metabolic
acidosis, with blood pH values often reaching *6.9–7.0.
Since the muscle groups involved in the arm-crank test are
relatively small, the elevated whole-body metabolic aci-
dosis suggests a dramatic acidosis within the contracting
muscles. Therefore, this test may provide the optimal
conditions to determine the effects of enhanced buffering
capacity.
Although evidence thus far is contradictory, there is
currently a paucity of research on the co-supplementation of
intracellular and extracellular buffering agents on exercise.
The lack of clear effects may be due to a number of con-
founding factors including exercise protocols unaffected by
increased buffering capacity and influenced by pacing
strategies. Furthermore, the evidence regarding the efficacy
of extracellular buffering agents appears much more vari-
able than that of beta-alanine, with a number of further
compounding factors contributing to this inconsistency.
6.3 Possible Side Effects
None of the investigations that evaluated co-supplementa-
tion of beta-alanine and sodium bicarbonate reported any
side effects outside of those already discussed for each
supplement separately. Therefore, similar to previous rec-
ommendations, individuals should consume beta-alanine
observing maximum single doses and daily doses, while
monitoring their response to sodium bicarbonate during
training or out of competition.
7 Conclusions and Future Perspectives
The evidence to support the effectiveness of intracellular
and extracellular buffers is substantial. Beta-alanine sup-
plementation can increase intracellular buffering capacity
through increased carnosine concentration. This includes
compelling evidence highlighting its ergogenic potential
across several exercise modalities and durations, specifically
1–10 min, and also within trained and non-trained popula-
tions. Importantly, the consistency of beta-alanine supple-
mentation to improve exercise performance has been shown
across individuals within the same exercise test [46, 54, 64].
Furthermore, current evidence suggests the side effects with
beta-alanine supplementation to be minimal and manage-
able. Since a low dose (3.2 g/day) can increase muscle
carnosine within 2 weeks [47] with chronic supplementation
resulting in sustained increased buffering capacity over time,
beta-alanine appears to be the most effective buffering agent
to improve exercise capacity and performance during single-
and repeated-bout high-intensity exercise.
The effects of increased extracellular buffering capacity on
exercise appear more inconsistent despite the fact that there
are three buffering agents capable of inducing blood alkalosis.
This is likely due to a high degree of inter-individual vari-
ability, which may have masked the true magnitude of effect
in studies employing a solitary intervention trial [124]. Future
studies should perform repeated interventional trials with the
same individuals to allow quantification of individual
responses and consistency in responses. The study by Van
Montfoort et al. [105], which directly compared these three
buffering agents, showed that sodium bicarbonate was most
effective in improving exercise performance, followed by
sodium lactate, with sodium citrate being the least effective.
Though the quality and quantity of research into sodium and
calcium lactate remains incomplete, the authors believe this
hierarchy of efficacy to be the most pertinent, though caution
is recommended when ingesting these extracellular buffering
supplements due to their associated side effects.
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